Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
EditorialEditorial

PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitors

Rafael Rosell and Ramón Palmero
Cancer Biology & Medicine June 2015, 12 (2) 71-73; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0026
Rafael Rosell
1Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona 08916, Spain
2Germans Trias i Pujol Health Sciences Institute and Hospital, Campus Can Ruti, Badalona 08916, Spain
3Instituto Oncológico Dr Rosell, Quiron Dexeus University Hospital, Barcelona 08028, Spain
4Pangaea Biotech, Barcelona 08028, Spain
5Molecular Oncology Research (MORe) Foundation, Barcelona 08028, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rrosell{at}iconcologia.net
Ramón Palmero
6Thoracic Oncology Unit, Department of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet, Barcelona 08908, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 12 no. 2 71-73
DOI 
https://doi.org/10.7497/j.issn.2095-3941.2015.0026

Published By 
Cancer Biology & Medicine
History 
  • Received April 8, 2015
  • Accepted May 4, 2015
  • Published online June 1, 2015.

Copyright & Usage 
Copyright: © 2015 Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

Cited By...

  • 8 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 12 (2)
Cancer Biology & Medicine
Vol. 12, Issue 2
1 Jun 2015
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitors
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitors
Rafael Rosell, Ramón Palmero
Cancer Biology & Medicine Jun 2015, 12 (2) 71-73; DOI: 10.7497/j.issn.2095-3941.2015.0026

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitors
Rafael Rosell, Ramón Palmero
Cancer Biology & Medicine Jun 2015, 12 (2) 71-73; DOI: 10.7497/j.issn.2095-3941.2015.0026
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Balancing global standards and regional nuances in breast cancer care: the role of guidelines, clinical research, precision medicine, and artificial intelligence in advancing quality of care for patients worldwide
  • Advances in TROP2-targeted antibody-drug conjugates for breast cancer therapy: into the new era
  • Precision immunotherapy for breast cancer: from biomarkers to clinical practice
Show more Editorial

Similar Articles

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire